Neurogene (NGNE) Shares Issued (2013 - 2020)

Neurogene's Shares Issued history runs 8 years deep, the most recent figure standing at $6.8 million for Q3 2020.

• Quarterly Shares Issued changed N/A year-over-year to $6.8 million in Q3 2020, while the trailing twelve-month figure through Sep 2020 was $6.8 million (changed N/A YoY) and the FY2019 annual result came in at $5.8 million, up 101.59% from the prior year.
• Shares Issued was $6.8 million for Q3 2020 at Neurogene, up from $983334.0 in the prior quarter.
• Across five years, Shares Issued topped out at $6.8 million in Q3 2020 and bottomed at $526197.0 in Q3 2016.
• A 5-year average of $2.2 million and a median of $1.4 million in 2016 frame the typical range for Shares Issued.
• Annual changes were most pronounced in 2017 — Shares Issued surged 294.06% — and 2019, when it tumbled 61.05%.
• Neurogene's Shares Issued stood at $1.4 million in 2016, then surged by 50.12% to $2.1 million in 2017, then jumped by 40.02% to $2.9 million in 2018, then soared by 101.59% to $5.8 million in 2019, then rose by 15.88% to $6.8 million in 2020.
• Business Quant data shows NGNE's Shares Issued at $6.8 million in Q3 2020, $983334.0 in Q2 2020, and $1.0 million in Q1 2020.